CMKLR1 and glioblastoma: Flow cytometric analysis of freshly resected GBM samples further verified that CMKLR1 was more highly expressed in CD45+ CD11b+ TAMs than in GFAP+ malignant cells (Fig. 4B), suggesting the possible involvement of TAMs in the chemerin-mediated GBM-promoting mechanism.